Donate

Journalism in the Public Interest

Prescriber Checkup

The Doctors and Drugs in Medicare Part D

Search for a Prescriber, City or Zip Code

|

About This Data

|

Related Story »

Prescriber Checkup » New Hampshire » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber	Claims Filled	Total Cost	Medicare Part D Patients	Claims for Brand Name Drugs	Schedule Two	Schedule Three	Dangerous Drugs to Seniors	Brand Name Drugs	Prescription Price
ROBERT DEWEY M.D. Cardiovascular Disease Manchester New Hampshire 03102	1,761	$94.3K	198 179 are 65+	24%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	24% prescriptions for brand name drugs Avg: 23%	$54 Average prescription price Avg: $72
WILLIAM BERNDT MD Cardiovascular Disease Exeter New Hampshire 03833	1,555	$104K	191 157 are 65+	24%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	24% prescriptions for brand name drugs Avg: 23%	$67 Average prescription price Avg: $72
WILLIAM GRAFF M.D. Cardiovascular Disease Manchester New Hampshire 03102	1,486	$66.1K	183 154 are 65+	15%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	15% prescriptions for brand name drugs Avg: 23%	$44 Average prescription price Avg: $72
SACHIN SAKSENA M.D. Cardiovascular Disease Rochester New Hampshire 03867	1,478	$74.2K	161 128 are 65+	20%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	20% prescriptions for brand name drugs Avg: 23%	$50 Average prescription price Avg: $72
JEFFREY LOCKHART M.D. Cardiovascular Disease Concord New Hampshire 03301	1,399	$42.8K	149 126 are 65+	14%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	14% prescriptions for brand name drugs Avg: 23%	$31 Average prescription price Avg: $72
MICHAEL METZGER MD Cardiovascular Disease Rochester New Hampshire 03867	1,372	$85.1K	211 182 are 65+	26%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	26% prescriptions for brand name drugs Avg: 23%	$62 Average prescription price Avg: $72
ANDREW COHEN M.D. Cardiovascular Disease Manchester New Hampshire 03102	1,314	$55K	182 157 are 65+	22%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	22% prescriptions for brand name drugs Avg: 23%	$42 Average prescription price Avg: $72
ROBERT BURKE MD Cardiovascular Disease Keene New Hampshire 03431	1,303	$69.9K	238 209 are 65+	22%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	22% prescriptions for brand name drugs Avg: 23%	$54 Average prescription price Avg: $72
NICHOLAS SKIADAS M.D. Cardiovascular Disease Lebanon New Hampshire 03756	1,300	$74.8K	104 90 are 65+	27%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	27% prescriptions for brand name drugs Avg: 23%	$58 Average prescription price Avg: $72
ERNEST PODRASKY MD Cardiovascular Disease Exeter New Hampshire 03833	1,284	$73.4K	153 129 are 65+	24%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	24% prescriptions for brand name drugs Avg: 23%	$57 Average prescription price Avg: $72
MICHAEL NEWTON M.D. Cardiovascular Disease Concord New Hampshire 03301	1,280	$63.7K	114 103 are 65+	21%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	21% prescriptions for brand name drugs Avg: 23%	$50 Average prescription price Avg: $72
MICHAEL JACUCH M.D. Cardiovascular Disease Portsmouth New Hampshire 03801	1,278	$111K	198 169 are 65+	29%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	29% prescriptions for brand name drugs Avg: 23%	$87 Average prescription price Avg: $72
PHILIP FITZPATRICK M.D. Cardiovascular Disease Manchester New Hampshire 03102	1,273	$64.6K	233 202 are 65+	15%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	15% prescriptions for brand name drugs Avg: 23%	$51 Average prescription price Avg: $72
EDWARD CATHERWOOD M.D. Cardiovascular Disease Lebanon New Hampshire 03756	1,271	$895K	151 131 are 65+	31%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	31% prescriptions for brand name drugs Avg: 23%	$704 Average prescription price Avg: $72
ALICE PASSER MD Cardiovascular Disease Exeter New Hampshire 03833	1,259	$66.6K	151 130 are 65+	19%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	19% prescriptions for brand name drugs Avg: 23%	$53 Average prescription price Avg: $72
LOUIS FINK M.D. Cardiovascular Disease Manchester New Hampshire 03102	1,250	$68.5K	176 147 are 65+	22%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	22% prescriptions for brand name drugs Avg: 23%	$55 Average prescription price Avg: $72
ALAN KAPLAN M.D. Cardiovascular Disease Manchester New Hampshire 03104	1,214	$65.5K	76 72 are 65+	21%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	21% prescriptions for brand name drugs Avg: 23%	$54 Average prescription price Avg: $72
AYESHA NAZEER M.D. Cardiovascular Disease Laconia New Hampshire 03246	1,205	$46.8K	117 102 are 65+	13%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	13% prescriptions for brand name drugs Avg: 23%	$39 Average prescription price Avg: $72
JON WAHRENBERGER M.D. Cardiovascular Disease Lebanon New Hampshire 03756	1,192	$64.4K	163 141 are 65+	20%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	20% prescriptions for brand name drugs Avg: 23%	$54 Average prescription price Avg: $72
ROBERT CAPODILUPO M.D. Cardiovascular Disease Manchester New Hampshire 03102	1,148	$115K	147 120 are 65+	15%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	15% prescriptions for brand name drugs Avg: 23%	$100 Average prescription price Avg: $72
ROBERT LOOTENS M.D. Cardiovascular Disease Laconia New Hampshire 03246	987	$40.3K	102 89 are 65+	15%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	15% prescriptions for brand name drugs Avg: 23%	$41 Average prescription price Avg: $72
CRAIG BERRY M.D. Cardiovascular Disease Manchester New Hampshire 03102	952	$66.9K	116 102 are 65+	26%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	1% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	26% prescriptions for brand name drugs Avg: 23%	$70 Average prescription price Avg: $72
KENNETH DELOGE M.D. Cardiovascular Disease Concord New Hampshire 03301	943	$208K	109 92 are 65+	21%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	21% prescriptions for brand name drugs Avg: 23%	$220 Average prescription price Avg: $72
DANIEL VAN BUREN M.D. Cardiovascular Disease Manchester New Hampshire 03102	847	$33.7K	143 119 are 65+	16%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	16% prescriptions for brand name drugs Avg: 23%	$40 Average prescription price Avg: $72
BRUCE ANDRUS M.D. Cardiovascular Disease Lebanon New Hampshire 03756	812	$166K	123 106 are 65+	25%	0% patients receiving schedule two controlled substances Avg: 0%	0% patients receiving schedule three controlled substances Avg: 0%	0% prescriptions for patients 65+ for potentially dangerous drugs Avg: 0%	25% prescriptions for brand name drugs Avg: 23%	$204 Average prescription price Avg: $72

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank